Heatwurx Price PerformanceNASDAQ PCSA traded up $0.08 on Tuesday, hitting $2.21. The company’s 50-day moving average price is $2.26 and its two-hundred day moving average price is $2.56. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Heatwurx currently has an average rating of “Hold” and an average target price of $25.00. Heatwurx Company Profile(Get Free Report)Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.